Comment from Gautam Dravid
AnonymousSupportIndividual
Summary: Gautam Dravid, a PhD-level professional, provides technical feedback on the draft guidance for New Approach Methodologies (NAMs) in drug development. He suggests specific clarifications regarding context-of-use examples, donor sourcing, cellular maturity, and reagent lot variability to improve the reliability and regulatory utility of NAM-derived data.
See attached file(s)